Pharma increases vaccine production as bird flu hits Europe

October 14, 2005
Manufacturing and Production

Pharmaceutical companies are being urged to step up vaccine production as the strain of bird flu that killed 59 people …

Pfizer wins UK Lipitor court battle

October 14, 2005
Sales and Marketing

Pfizer has won an important legal battle to maintain its UK patent on best-selling cholesterol drug Lipitor.The UK High Court …

Sanofi-Aventis launch new short-acting insulin competitor Apidra

October 13, 2005
Sales and Marketing

Apidra, a new short-acting insulin analogue, has been launched in the UK by Sanofi-Aventis.Short-acting analogues have a faster onset of …

EMEA reforms to speed drug approval

October 13, 2005
Sales and Marketing

Europe's medicines regulator is looking to communicate more effectively with pharma companies as part of a drive to accelerate drug …

Merck looks to rebuild reputation one year on from Vioxx

October 13, 2005
Sales and Marketing

Merck looks set to launch a new public relations campaign across Europe in an attempt to repair damage done to …

Unions vote against NHS ‘privatisation’

October 13, 2005

The government lost the vote at its party conference on expanding the role of the private sector in the NHS.A …

VNU shareholders rebel over IMS bid

October 13, 2005
Sales and Marketing

A significant minority of shareholders in VNU are against its planned $7 billion acquisition of pharmaceutical information company IMS Health.The …

Reducing POM to P headaches

October 12, 2005
Sales and Marketing

Following an eight-week period of public consultation, the Committee on Safety of Medicines is to shortly advise health ministers about …

Creative Lynx to work on Novartis transplantation brands

October 12, 2005
Medical Communications

Novartis has awarded advertising accounts for its ophthalmology and transplantation portfolios to Manchester-based advertising agency Creative Lynx.The pharma company held …

GPs need pharma expertise

October 5, 2005

GPs are calling out for pharmaceutical companies to provide them with management skills as they take on a new role …

Resolute selected for IBD campaign

October 3, 2005
Medical Communications

Procter & Gamble has chosen Resolute Communications to conduct a combined PR and medical education programme for its inflammatory bowel …

Pharma cast as ‘bad guys’ in Hollywood blockbuster

September 30, 2005
Sales and Marketing

A new Hollywood thriller featuring the pharmaceutical industry as the 'bad guys' is to hit UK screens next week.The Constant …

Genzyme opens first European research centre in Cambridge

September 30, 2005
Research and Development

Genzyme, one of the most successful US biotech companies, has opened its first European research centre in Cambridge, UK – …

Davis to leave Takeda UK

September 30, 2005
Sales and Marketing

Andy Davis, the high-profile managing director of Takeda UK is to leave the company.Davis is best known for overseeing a …

New leader for FDA in turmoil

September 30, 2005
Sales and Marketing

Andrew von Eschenbach has been appointed the new acting head of the FDA after the surprise resignation of Lester Crawford.Crawford …

NICE seeks urgent fix for slow appraisals

September 29, 2005
Sales and Marketing

Patients waiting for access to new, more effective medicines could be prescribed them earlier if new proposals are adopted.NICE, the …

The inspector calls

September 28, 2005
Research and Development

I have become a pharmacovigilance bore within my company, a prophet of doom. It is worse than that, because for …

Astellas launches Flomaxtra XL

September 27, 2005
Sales and Marketing

Astellas has launched Flomaxtra XL, a new treatment for the symptoms of BPH or benign prostatic hyperplasia.The condition is the …

Sains

Lilly increasing investment in UK R&D

September 23, 2005
Research and Development

 Lilly has opened a new  Â£26 million UK research facility, a move which underlines its commitment to developing medicines in …

Novartis pipeline promises cardiovascular advances

September 22, 2005
Research and Development

Novartis hopes to expand its presence in cardiovascular medicine with the filing next year of two potentially first-in-class products with …

The Gateway to Local Adoption Series

Latest content